These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Early Pseudomonas aeruginosa infection in individuals with cystic fibrosis: is susceptibility testing justified? Macdonald D; Cuthbertson L; Doherty C; Campana S; Ravenni N; Taccetti G; Govan JR J Antimicrob Chemother; 2010 Nov; 65(11):2373-5. PubMed ID: 20837573 [TBL] [Abstract][Full Text] [Related]
30. Antibiotic susceptibility testing in early and chronic respiratory infections with Pseudomonas aeruginosa. Foweraker JE; Govan JR J Cyst Fibros; 2013 May; 12(3):302. PubMed ID: 22959655 [No Abstract] [Full Text] [Related]
31. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden. Knudsen PK; Olesen HV; Høiby N; Johannesson M; Karpati F; Laerum BN; Meyer P; Pressler T; Lindblad A; J Cyst Fibros; 2009 Mar; 8(2):135-42. PubMed ID: 19157995 [TBL] [Abstract][Full Text] [Related]
32. Establishing the diagnosis of chronic colonization with Pseudomonas aeruginosa of cystic fibrosis patients: Comparison of the European consensus criteria with genotyping of P. aeruginosa isolates. Jonckheere L; Schelstraete P; Van Simaey L; Van Braeckel E; Willekens J; Van Daele S; De Baets F; Vaneechoutte M J Cyst Fibros; 2018 Nov; 17(6):729-735. PubMed ID: 29655935 [TBL] [Abstract][Full Text] [Related]
33. Impact of a Reduction in Susceptibility Testing for Ponce MC; Svendsen E; Steed L; Flume PA Am J Respir Crit Care Med; 2020 Jan; 201(1):114-116. PubMed ID: 31469583 [No Abstract] [Full Text] [Related]
35. Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa. Klepac-Ceraj V; Lemon KP; Martin TR; Allgaier M; Kembel SW; Knapp AA; Lory S; Brodie EL; Lynch SV; Bohannan BJ; Green JL; Maurer BA; Kolter R Environ Microbiol; 2010 May; 12(5):1293-303. PubMed ID: 20192960 [TBL] [Abstract][Full Text] [Related]
36. Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study. Hansen CR; Pressler T; Koch C; Høiby N J Cyst Fibros; 2005 Mar; 4(1):35-40. PubMed ID: 15752679 [TBL] [Abstract][Full Text] [Related]
37. Treatment options for cystic fibrosis: case study and panel discussion. Kuhn RJ; Flume PA Pharmacotherapy; 2002 Mar; 22(3 Pt 2):86S-87S. PubMed ID: 11898886 [No Abstract] [Full Text] [Related]
38. Bacteriological studies of bronchial secretions in 19 cases of cystic fibrosis. Feigelson J; Pecau Y Bibl Paediatr; 1967; 86():214-26. PubMed ID: 4964164 [No Abstract] [Full Text] [Related]
39. Approaches to the treatment of initial Pseudomonas aeruginosa infection in children who have cystic fibrosis. Lahiri T Clin Chest Med; 2007 Jun; 28(2):307-18. PubMed ID: 17467550 [TBL] [Abstract][Full Text] [Related]
40. Pseudomonas colonization in cystic fibrosis. A study of 160 patients. Kulczycki LL; Murphy TM; Bellanti JA JAMA; 1978 Jul; 240(1):30-4. PubMed ID: 96277 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]